Using Failure Mode, Effect and Criticality Analysis to improve safety in the cancer treatment prescription and administration process

[1]  H. Blum,et al.  Should routine risk reduction procedures for the prevention and control of pandemics become a standard in all oncological outpatient clinics? The prospective COVID-19 cohort study: protect-CoV , 2022, Medical Oncology.

[2]  R. Rabiei,et al.  Effects of Guideline-based Computerized Provider Order Entry Systems on the Chemotherapy Order Process: a Systematic Review , 2022, Acta informatica medica : AIM : journal of the Society for Medical Informatics of Bosnia & Herzegovina : casopis Drustva za medicinsku informatiku BiH.

[3]  G. De Luca,et al.  Using Failure Mode, Effect and Criticality Analysis to Improve Safety in the COVID Mass Vaccination Campaign , 2021, Vaccines.

[4]  C. Dyer.  Identifying patients in outpatient clinics must be improved, says safety watchdog , 2021, BMJ.

[5]  A. Hassol,et al.  Making Healthcare Safer III: A Critical Analysis of Existing and Emerging Patient Safety Practices [Internet] , 2020 .

[6]  Ş. Apikoglu-Rabus,et al.  Significance of a clinical pharmacist-led comprehensive medication management program for hospitalized oncology patients , 2020, International Journal of Clinical Pharmacy.

[7]  D. Jackson,et al.  The wicked problem of patient misidentification: How could the technological revolution help address patient safety? , 2019, Journal of clinical nursing.

[8]  Molly Billstein‐Leber,et al.  ASHP Guidelines on Preventing Medication Errors in Hospitals , 2018, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[9]  Pieter Cornu,et al.  Clinical Decision Support Systems for Drug Allergy Checking: Systematic Review , 2018, Journal of medical Internet research.

[10]  P. Shekelle.  Clinical Practice Guidelines: What's Next? , 2018, JAMA.

[11]  M. Thibault,et al.  Failure Mode, Effect, and Criticality Analysis of the Parenteral Nutrition Process in a Mother–Child Hospital: The AMELIORE Study , 2018, Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition.

[12]  J. Kelly,et al.  Frequency of Chemotherapy Medication Errors: A Systematic Review , 2018 .

[13]  H. Burke.  Improving the safety and quality of cancer care , 2017, Cancer.

[14]  Sabine Brosch,et al.  Medication Errors: New EU Good Practice Guide on Risk Minimisation and Error Prevention , 2016, Drug Safety.

[15]  V. Faus,et al.  GRP-175 Smart Infusion Pumps in Chemotherapy Administration , 2013 .

[16]  Mark Spranca,et al.  Reduction in medication errors in hospitals due to adoption of computerized provider order entry systems , 2013, J. Am. Medical Informatics Assoc..

[17]  D. Cousins,et al.  A review of medication incidents reported to the National Reporting and Learning System in England and Wales over 6 years (2005–2010) , 2012, British journal of clinical pharmacology.

[18]  Heather McKenzie,et al.  Chemotherapy outpatients’ unplanned presentations to hospital: a retrospective study , 2011, Supportive Care in Cancer.

[19]  Shelley A. Rushton,et al.  The Clinical Oncological Society of Australia (COSA) guidelines for the safe prescribing, dispensing and administration of cancer chemotherapy , 2010, Asia-Pacific journal of clinical oncology.

[20]  Gerry Armitage,et al.  A practical guide to failure mode and effects analysis in health care: making the most of the team and its meetings. , 2010, Joint Commission journal on quality and patient safety.

[21]  E. Redfern,et al.  Improving communication in the emergency department , 2009, Emergency Medicine Journal.

[22]  L. Schulmeister,et al.  Patient misidentification in oncology care. , 2008, Clinical journal of oncology nursing.

[23]  Patrice L Spath,et al.  Using failure mode and effects analysis to improve patient safety. , 2003, AORN journal.

[24]  Barry R. Goldspiel,et al.  ASHP Guidelines on Preventing Medication Errors with Antineoplastic Agents , 2002 .

[25]  C. Pamer,et al.  Retrospective analysis of mortalities associated with medication errors. , 2001, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[26]  N. Laird,et al.  Incidence of Adverse Drug Events and Potential Adverse Drug Events: Implications for Prevention , 1995 .

[27]  N M Davis,et al.  Failure mode and effects analysis: a novel approach to avoiding dangerous medication errors and accidents. , 1994, Hospital pharmacy.

[28]  K. Sandrik.  Oncology: who's managing outpatient programs? , 1990, Hospitals.

[29]  Ugo Moretti,et al.  Drug-Related Deaths , 2008, Drug safety.

[30]  J. Vandenbroucke,et al.  ISOPP standards of practice. Safe handling of cytotoxics. , 2007, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

[31]  C. Monaco,et al.  Prevenzione degli errori di terapia in oncologia , 2005 .

[32]  Am J Health-Syst Pharm.  ASHP guidelines on preventing medication errors with antineoplastic agents. , 2002, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[33]  William R. Hendee,et al.  To Err is Human: Building a Safer Health System , 2001 .